| Term/Question | Description/Answer |
|---|---|
| Pharmacy Benefits Manager (PBM) | An outsourced company employed by the insurance company to manage prescription drug benefits. |
| Condition treated with allopurinol (Zyloprim), colchicine, febuxostat (Uloric) | GOUT |
| Environmental Protection Agency (EPA) | Protects people and the environment from significant health risks, sponsors and conducts research, and develops and enforces environmental regulations. |
| Condition treated with Ropinirole (Requip), benztropine (Cogentin), entacapone (Comtan), or rotigotine (Neupro) | Parkinson’s disease |
| State Boards of Pharmacy (BOP) | Regulate the practice of pharmacy by state; they also focus on public health and the enforcement of state laws. |
| DEA Form 41 | Used for destroying or sending back controlled drugs. |
| BIOAVAILABILITY | The usable amount of the drug that reaches the body’s circulation. |
| Intramuscular (IM) injection | An injection into a muscle; a medication delivery route. |
| Intradermal injection | The administration of medication by injection into the middle layers of the skin. |
| Drug duplication | A situation when a drug is prescribed that has the same active ingredient as a current medication taken by the patient. |
| Subcutaneous (subcut) | Under the skin. |
| DAW | Dispense as written. |
| Therapeutic substitution | The substitution of a prescribed drug with another medication that produces the same therapeutic effect. |
| SSRIs (Selective Serotonin Reuptake Inhibitors) | Used for treating depression. Examples: citalopram (Celexa), fluoxetine (Prozac), paroxetine (Paxil), sertraline (Zoloft). |
| Intravenous (IV) injection | An injection directly into a vein; a medication delivery route. |
| SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors) | Used for treating depression. Examples: desvenlafaxine (Pristiq), duloxetine (Cymbalta), mirtazapine (Remeron), venlafaxine (Effexor). |
| Resource Conservation and Recovery Act of 1976 | Gave the EPA complete authority over the disposal of hazardous substances. |
| DEA Form 106 | Report of theft or loss of controlled substances. |
| Agonist | A compound that binds to a receptor and stimulates activity. |
For those looking to expand their knowledge of pharmacy, our comprehensive table provides key insights into various aspects of pharmacy practice, including medication management, drug treatments for specific conditions, and important regulatory considerations.
From understanding the role of Pharmacy Benefits Managers (PBMs) and State Boards of Pharmacy (BOP) to learning about the specifics of drug administration routes and the importance of BIOAVAILABILITY, this table is a valuable resource for anyone preparing for pharmacy-related examinations or seeking to enhance their professional expertise.
To dive deeper into these topics and access a wealth of additional information and resources, we highly recommend visiting our dedicated page at PTCB Practice Test.
